Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Urinary Bladder Neoplasms × tremelimumab × 90 days × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Hepatocellular 10 Carcinoma, Non-Small-Cell Lung 5 Liver Neoplasms 4 Small Cell Lung Carcinoma 2 Mesothelioma, Malignant 2 Lung Neoplasms 2 Urothelial Cancer 1 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Squamous Cell Carcinoma of Head and Neck 1 Seminoma 1 Pancreatic Neoplasms 1 Nonseminomatous germ cell tumor 1 Non Small Cell Lung Cancer NSCLC 1 Neoplasms, Germ Cell and Embryonal 1 Metastatic Malignant Female Reproductive System Neoplasm 1 Mesothelioma 1 Lung Cancer Metastatic 1 Liver Cirrhosis 1 Hydronephrosis 1 Germinoma 1 Fallopian Tube Neoplasms 1 Dysgerminoma 1 Diabetes Mellitus, Insulin-Dependent, 12 1 Colorectal Neoplasms 1 Adenocarcinoma, Follicular 1 Adenocarcinoma Of Esophagus 1

Interventions

Gemcitabine 26 pembrolizumab 19 Cisplatin 19 Specimen Handling 15 Magnetic Resonance Spectroscopy 15 durvalumab 10 Nivolumab 9 enfortumab vedotin 8 avelumab 8 atezolizumab 7 Carboplatin 7 Mitomycin 6 Docetaxel 6 Cystoscopy 6 Cystectomy 6 Radiation 5 Paclitaxel 5 Biopsy 5 sacituzumab govitecan 4 Transurethral Resection of Bladder 4 Standard of Care 4 Radiotherapy 4 Ipilimumab 4 Fluorouracil 4 erdafitinib 3 dehydroftorafur 3 cabozantinib 3 Practice Guidelines as Topic 3 Platinum 3 Mitozytrex 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03682068 2026-02-03

NILE

AstraZeneca

Phase 3 Active not recruiting

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡